FDA Further Limits Johnson & Johnson Covid Vaccine

FDA Further Limits Johnson & Johnson Covid Vaccine

Johnson & & Johnson was eclipsed long ago by Pfizer and Moderna in the country’s vaccination project; federal authorities have said the mRNA vaccines produced by those companies are both more secure and more reliable. In a statement, Johnson & & Johnson said the F.D.A.’s action reflected the already-known risk of the side result, not new data on the rate at which it takes place. The number of deaths attributed to the disorder activated by the Johnson & & Johnson’s vaccine does not appear to have risen much, if at all. About 17 million Americans have actually now gotten one dosage of Johnson & & Johnson’s vaccine, and another 1.5 million have actually gotten a booster dose, according to the C.D.C.’s data.

Johnson & & Johnson was eclipsed long ago by Pfizer and Moderna in the nation’s vaccination campaign; federal officials have said the mRNA vaccines produced by those business are both safer and more reliable. The number of deaths associated to the condition triggered by the Johnson & & Johnson’s vaccine does not appear to have increased much, if at all. About 17 million Americans have actually now gotten one dosage of Johnson & & Johnson’s vaccine, and another 1.5 million have gotten a booster dosage, according to the C.D.C.’s data.

Leave a Reply

Your email address will not be published. Required fields are marked *


*